40 related articles for article (PubMed ID: 17525375)
1. HMG-CoA Reductase Inhibitors Suppress Monosodium Urate-Induced NLRP3 Inflammasome Activation through Peroxisome Proliferator-Activated Receptor-γ Activation in THP-1 Cells.
Kim SK; Choe JY; Kim JW; Park KY
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111279
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis.
Claesen K; Roth L; Mertens JC; Hermans K; Sim Y; Hendriks D
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34684024
[TBL] [Abstract][Full Text] [Related]
3. LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL.
Chapman MJ; Orsoni A; Tan R; Mellett NA; Nguyen A; Robillard P; Giral P; Thérond P; Meikle PJ
J Lipid Res; 2020 Jun; 61(6):911-932. PubMed ID: 32295829
[TBL] [Abstract][Full Text] [Related]
4. Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer.
Hayashi T; Fujita K; Matsushita M; Nonomura N
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31408948
[TBL] [Abstract][Full Text] [Related]
5. Statins decrease leptin expression in human white adipocytes.
Singh P; Zhang Y; Sharma P; Covassin N; Soucek F; Friedman PA; Somers VK
Physiol Rep; 2018 Jan; 6(2):. PubMed ID: 29372612
[TBL] [Abstract][Full Text] [Related]
6. Statins: antimicrobial resistance breakers or makers?
Ko HHT; Lareu RR; Dix BR; Hughes JD
PeerJ; 2017; 5():e3952. PubMed ID: 29085751
[TBL] [Abstract][Full Text] [Related]
7. Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia.
Orsoni A; Thérond P; Tan R; Giral P; Robillard P; Kontush A; Meikle PJ; Chapman MJ
J Lipid Res; 2016 Nov; 57(11):2073-2087. PubMed ID: 27581680
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.
Rigassi L; Barchiesi Bozzolo F; Lucchinetti E; Zaugg M; Fingerle J; Rosselli M; Imthurn B; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2015 Dec; 309(12):E995-1007. PubMed ID: 26487003
[TBL] [Abstract][Full Text] [Related]
9. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.
Kuo KK; Wu BN; Liu CP; Yang TY; Kao LP; Wu JR; Lai WT; Chen IJ
J Lipid Res; 2015 Nov; 56(11):2070-84. PubMed ID: 26351364
[TBL] [Abstract][Full Text] [Related]
10. Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors.
Shinohara M; Sato N; Shimamura M; Kurinami H; Hamasaki T; Chatterjee A; Rakugi H; Morishita R
Front Aging Neurosci; 2014; 6():71. PubMed ID: 24795626
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.
Parada B; Reis F; Pinto Â; Sereno J; Xavier-Cunha M; Neto P; Rocha-Pereira P; Mota A; Figueiredo A; Teixeira F
Int J Mol Sci; 2012; 13(7):8482-8499. PubMed ID: 22942715
[TBL] [Abstract][Full Text] [Related]
12. Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.
Luoma PV
Curr Mol Med; 2011 Jul; 11(5):391-400. PubMed ID: 21568932
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
Huang XS; Zhao SP; Bai L; Hu M; Zhao W; Zhang Q
Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
[TBL] [Abstract][Full Text] [Related]
14. Confronting an influenza pandemic with inexpensive generic agents: can it be done?
Fedson DS
Lancet Infect Dis; 2008 Sep; 8(9):571-6. PubMed ID: 18420459
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.
Paumelle R; Staels B
Circ Res; 2007 May; 100(10):1394-5. PubMed ID: 17525375
[No Abstract] [Full Text] [Related]
16. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
17. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway.
Paumelle R; Blanquart C; Briand O; Barbier O; Duhem C; Woerly G; Percevault F; Fruchart JC; Dombrowicz D; Glineur C; Staels B
Circ Res; 2006 Feb; 98(3):361-9. PubMed ID: 16397146
[TBL] [Abstract][Full Text] [Related]
18. Statins downregulate myeloperoxidase gene expression in macrophages.
Kumar AP; Reynolds WF
Biochem Biophys Res Commun; 2005 Jun; 331(2):442-51. PubMed ID: 15850779
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
Paumelle R; Staels B
Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
